Overview

Bioavailability of Nasal Epinephrine

Status:
Completed
Trial end date:
2021-09-28
Target enrollment:
Participant gender:
Summary
A Study to Compare the Bioavailability of Epinephrine following a Single Nasal Dose of FMXIN002 Microspheres Powder with Epinephrine 0.3 mg Intramuscular Injection in Adult Subjects with Seasonal Allergic Rhinitis with and without Nasal Allergen Challenge
Phase:
Phase 1
Details
Lead Sponsor:
Nasus Pharma
Treatments:
Epinephrine
Epinephryl borate
Racepinephrine